Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
agreed.
Indeed it does.
New Form D filing at the SEC:
This confirms Terren Peizer as CEO and Jonathan Adams as COO.
http://archive.fast-edgar.com//20180710/A82ZKQ2CZW228ZL2222G2Z32L8ACZC22DMA2/
"3. Related Persons
Last Name First Name Middle Name
Peizer Terren
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: X Executive Officer X Director Promoter
Clarification of Response (if Necessary):
Chief Executive Officer
Last Name First Name Middle Name
Adams Jonathan
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: X Executive Officer X Director Promoter
Clarification of Response (if Necessary):
President and Chief Operating Officer
Last Name First Name Middle Name
Anderson Julie
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: X Executive Officer X Director Promoter
Clarification of Response (if Necessary):
Corporate Secretary
Last Name First Name Middle Name
Do Cuong
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: Executive Officer X Director Promoter
Clarification of Response (if Necessary):
Last Name First Name Middle Name
Lang Jim
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: Executive Officer X Director Promoter
Clarification of Response (if Necessary):
Last Name First Name Middle Name
Kumar Hari
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: Executive Officer X Director Promoter
Clarification of Response (if Necessary):
Last Name First Name Middle Name
Sherman Michael
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MICHIGAN 01915
Relationship: Executive Officer X Director Promoter
Clarification of Response (if Necessary):
Last Name First Name Middle Name
Sooch Mina
Street Address 1 Street Address 2
c/o BioVie Inc. 100 Cummings Center, Suite 247-C
City State/Province/Country ZIP/PostalCode
Beverly MASSACHUSETTS 01915
Relationship: Executive Officer X Director Promoter"
I just had a conversation with Jonathan Adams of BIVI. He and I are both on travel, hence it was short. Wording below is mine.
With this financing by Aquitas, Jonathan is very excited as to BioVie's prospects, and, if results come out as expected, they anticipate charging ahead to finish the Phase 2a and begin Phase 2b. FDA may further agree to Phase 2B transitioning into a Phase 3 (if they are lucky, in my view).
With the funding from Aquitas and their majority interest, Aquitas staff will take over the CEO slot and Jonathan will become COO and President, with no change in his actual day-to-day duties.
I'll ask the CEO if he can give us the simplified explanation. No guarantee of a response, but I will ask.
Hi BD, Sounds just like I would have summarized it. Dilution is inevitable for startup bios and I think this entity would not have put in a dime if they thought this was not going to carry us thru to approval. I've been looking for Jonathan Adams to pull a rabbit out of his hat...and I think this is the rabbit.
Might be just enough funds to do what they need.
And a sched 14c, with an increase in authorized shares:
Important New Sched 13D:
http://archive.fast-edgar.com//20180703/ATZNUQ2CZC227ZZ2222C2ZZZGV2NZ6U7Q2A2/
I agree that terlipressin should be complimentary to drugs for NASH. I've been here since NNAB (earlier incarnation) days and invested more once the new people took over and gave it this focus.
Hi Zino, As Chaka said: "welcome aboard." What initially piqued your interest in BioVie?
Shouldn't forget dad any time.
Certainly, the extra money they received will move them further along.
Akika, asking someone why they own shares is fine. Asking how many is just likely to solicit inaccurate information. "On the internet," as a New Yorker cartoon once propounded, "nobody knows you're a dog."
My guess is BIVI is putting shares to Aspire, which then unloads most of them thru the market. 96,939,603 shares outstanding at 3/31/18 vs 91,493,146 at 3/31/2017.
I still have not finished my review.
Ugh. Too many things intruding on my review of the quarterly report. Wife seems to think I am at her beck and call. Hmm...guess so.
Yes. Absent more facts, all we can do is hope for the best ...and maybe buy a few more shares.
At least some signs of life in today's trading.
You've directly responded to his posts. Under the IHub system, he would get an email telling him about that.
They will PR any significant information like that, per the CEO
Sounds great FUN. Wish I had been there.
OK, please let us know.
Let us know the comparison when you get more "stock."
Have you tried the 12 YO?
Good Ocean cask strength, but of course at Casker's price.
...and the 12 year old:
And Caskers is promoting the 16 year Knappogue:
12 great Irish whiskeys to drink in 2018. Includes Knappogue Castle 21 year.
https://www.mensjournal.com/food-drink/a-dozen-great-bottles-of-irish-whiskey-to-drink-in-2018/knappogue-21-year-old-single-malt/
Knappogue 21 Year Old Single Malt
Knappogue makes a lot of our lists, but this special 21-year release should make yours. 21 is actually a blend of 21-and-23-year-old single malts, and the result is a heady, brooding whiskey for an Irish single malt, because two-plus decades really gets a lot of complexity out of ex-bourbon casks. Clove and cinnamon and vanilla make an appearance on a backdrop that is starting to show just a few hints of leather. It’s an incredible sipping whiskey—unfortunately they only made 1,400 bottles.
[$200; knappoguewhiskey.com]
Don't be a wuss. Get out there on the course with your orange balls. lol
FUN, Especially like that gif of you eating in front of the TV.
FUN, We are in full agreement.
Fun, I think they are busy just trying to deal with the increase in demand for their products. They may not want to do that much promotion at the moment.
Good questions.
Nice summary FUN and very satisfying (to me) progress for ROX.
Chaka,
Well, I'm not happy with the share price either, or the present level of cash. I don't know what to say, beyond hoping Jonathan Adams has a rabbit ... waiting to be pulled out of his hat.
As a long-time biotech investor I have had to learn patience.
Good question. When you find out, PLMK.
mmmmmm.
I'll take the credit this time for the travel MOJO. Thanks.
Next time it's your turn again.
Fun, You are giving Zacks far too much credit for their perspicacity.
Sounds great, FUN.